Impact of interleukin 6 -174G>C polymorphism on obesity-related metabolic disorders in people with excess in body weight

Metabolism: Clinical and Experimental

Volumn 56, Issue 12, 2007, Pages 1643-1648

  Goyenechea, Estibaliz ^a   Parra, Dolores ^a   Martínez, J Alfredo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 6;

ADULT; ARTICLE; BODY MASS; CAUCASIAN; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOTE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VOLUNTEER;

ADULT; BLOOD PRESSURE; CHOLESTEROL; DYSLIPIDEMIAS; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 35848967014     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.07.005     Document Type: Article

References (45)

1. Sundell J. Obesity and diabetes as risk factors for coronary artery disease: from the epidemiological aspect to the initial vascular mechanisms. Diabetes Obes Metab 7 (2005) 9-20
2. Ravussin E. Metabolic differences and the development of obesity. Metabolism 44 (1995) 12-14
3. Martinez J.A. Body-weight regulation: causes of obesity. Proc Nutr Soc 59 (2000) 337-345
4. Yudkin J.S., Juhan-Vague I., Hawe E., et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 53 (2004) 852-857
5. Wexler D.J., Hu F.B., Manson J.E., et al. Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. Obes Res 13 (2005) 1772-1783
6. Fernandez-Real J.M., and Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24 (2003) 278-301
7. Yudkin J.S., Kumari M., Humphries S.E., et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
8. Vozarova B., Weyer C., Hanson K., et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9 (2001) 414-417
9. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83 (1998) 847-850
10. Pickup J.C., Mattock M.B., Chusney G.D., et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40 (1997) 1286-1292
11. Deepa R., Velmurugan K., Arvind K., et al. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance-the Chennai Urban Rural Epidemiology Study (CURES). Metabolism 55 (2006) 1232-1238
12. Fernandez-Real J.M. Genetic predispositions to low-grade inflammation and type 2 diabetes. Diabetes Technol Ther 8 (2006) 55-66
13. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
14. Hulkkonen J., Pertovaara M., Antonen J., et al. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology 40 (2001) 656-661
15. Yang X., Jansson P.A., Pellme F., et al. Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity. Obes Res 13 (2005) 813-817
16. Jones K.G., Brull D.J., Brown L.C., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265
17. Goyenechea E., Parra M.D., and Martinez Hernandez J.A. Role of IL-6 and its -174G>C polymorphism in weight management and in the metabolic comorbidities associated with obesity. An Sist Sanit Navar 28 (2005) 357-366
18. Vozarova B., Fernandez-Real J.M., Knowler W.C., et al. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 112 (2003) 409-413
19. Illig T., Bongardt F., Schopfer A., et al. Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 5053-5058
20. Mohlig M., Boeing H., Spranger J., et al. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 1885-1890
21. Humphries S.E., Luong L.A., Ogg M.S., et al. The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22 (2001) 2243-2252
22. Brown C.V., Martin M.J., Shoemaker W.C., et al. The effect of obesity on bioimpedance cardiac index. Am J Surg 189 (2005) 547-550
23. Goyenechea E., Parra M.D., and Martinez J.A. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptor-gamma2 gene polymorphisms. Br J Nutr 96 (2006) 965-972
24. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
25. Parra M.D., Martinez de Morentin B.E., and Martinez J.A. Postprandial insulin response and mitochondrial oxidation in obese men nutritionally treated to lose weight. Eur J Clin Nutr 59 (2005) 334-340
26. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
27. Berthier M.T., Paradis A.M., Tchernof A., et al. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 48 (2003) 14-19
28. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
29. Pradhan A.D., Manson J.E., Rifai N., et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
30. Bastard J.P., Maachi M., Van Nhieu J.T., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 87 (2002) 2084-2089
31. Parra M.D., Martinez de Morentin B.E., and Alfredo Martinez J. Impact of weight loss on cortisol secretion in obese men with and without metabolic syndrome features. Nutr Metab Cardiovasc Dis 16 (2006) 28-34
32. Pi-Sunyer F.X. Pathophysiology and long-term management of the metabolic syndrome. Obes Res 12 Suppl (2004) 174S-180S
33. Herbert A., Liu C., Karamohamed S., et al. BMI modifies associations of IL-6 genotypes with insulin resistance: the Framingham Study. Obesity 14 (2006) 1454-1461
34. Dedoussis G.V., Manios Y., Choumerianou D.M., et al. The IL-6 gene G-174C polymorphism related to health indices in Greek primary school children. Obes Res 12 (2004) 1037-1041
35. Libra M., Signorelli S.S., Bevelacqua Y., et al. Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease. J Clin Pathol 59 (2006) 211-215
36. Hamid Y.H., Rose C.S., Urhammer S.A., et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 48 (2005) 251-260
37. Fernandez-Real J.M., Broch M., Vendrell J., et al. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85 (2000) 1334-1339
38. Stephens J.W., Hurel S.J., Cooper J.A., et al. A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol Genet Metab 82 (2004) 180-186
39. Wernstedt I., Eriksson A.L., Berndtsson A., et al. A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord 28 (2004) 1272-1279
40. Huth C., Heid I.M., Vollmert C., et al. IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes 55 (2006) 2915-2921
41. Qi L., van Dam R.M., Meigs J.B., et al. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet 15 (2006) 1914-1920
42. Takakura Y., Yoshida T., Yoshioka K., et al. Angiotensinogen gene polymorphism (Met235Thr) influences visceral obesity and insulin resistance in obese Japanese women. Metabolism 55 (2006) 819-824
43. Halverstadt A., Phares D.A., Roth S., et al. Interleukin-6 genotype is associated with high-density lipoprotein cholesterol responses to exercise training. Biochim Biophys Acta 1734 (2005) 143-151
44. Kubaszek A., Pihlajamaki J., Punnonen K., et al. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 52 (2003) 558-561
45. Lachin J.M. Operating characteristics of sample size re-estimation with futility stopping based on conditional power. Stat Med 25 (2006) 3348-3365